105 related articles for article (PubMed ID: 9402399)
1. IgG response to pneumococcal polysaccharide-protein conjugate appears similar to IgG response to polysaccharide in bone marrow transplant recipients and healthy adults.
Storek J; Mendelman PM; Witherspoon RP; McGregor BA; Storb R
Clin Infect Dis; 1997 Nov; 25(5):1253-5. PubMed ID: 9402399
[No Abstract] [Full Text] [Related]
2. Immunogenicity of Haemophilus influenzae type b conjugate vaccine in allogeneic bone marrow recipients.
Barra A; Cordonnier C; Preziosi MP; Intrator L; Hessel L; Fritzell B; Preud'homme JL
J Infect Dis; 1992 Nov; 166(5):1021-8. PubMed ID: 1402013
[TBL] [Abstract][Full Text] [Related]
3. Impaired polysaccharide responses in immunodeficient patients: relevance to bone marrow transplant patients.
Ambrosino DM
Bone Marrow Transplant; 1991; 7 Suppl 3():48-51. PubMed ID: 1855089
[TBL] [Abstract][Full Text] [Related]
4. Correlation between serum IgG-2 concentrations and the antibody response to bacterial polysaccharide antigens.
Siber GR; Schur PH; Aisenberg AC; Weitzman SA; Schiffman G
N Engl J Med; 1980 Jul; 303(4):178-82. PubMed ID: 6966763
[TBL] [Abstract][Full Text] [Related]
5. A comparison of early and late vaccination with Haemophilus influenzae type b conjugate and pneumococcal polysaccharide vaccines after allogeneic BMT.
Parkkali T; Käyhty H; Ruutu T; Volin L; Eskola J; Ruutu P
Bone Marrow Transplant; 1996 Nov; 18(5):961-7. PubMed ID: 8932852
[TBL] [Abstract][Full Text] [Related]
6. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK.
Hazlewood M; Nusrat R; Kumararatne DS; Goodall M; Raykundalia C; Wang DG; Joyce HJ; Milford-Ward A; Forte M; Pahor A
Clin Exp Immunol; 1993 Aug; 93(2):157-64. PubMed ID: 8348740
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccines.
Lancet; 1978 Jan; 1(8056):131-2. PubMed ID: 87558
[No Abstract] [Full Text] [Related]
8. Avidity of IgG for Streptococcus pneumoniae type 6B and 23F polysaccharides in infants primed with pneumococcal conjugates and boosted with polysaccharide or conjugate vaccines.
Anttila M; Eskola J; Ahman H; Käyhty H
J Infect Dis; 1998 Jun; 177(6):1614-21. PubMed ID: 9607841
[TBL] [Abstract][Full Text] [Related]
9. Immune responses to polysaccharides: lessons from humans and mice.
González-Fernández A; Faro J; Fernández C
Vaccine; 2008 Jan; 26(3):292-300. PubMed ID: 18160186
[TBL] [Abstract][Full Text] [Related]
10. IgG responses to protein-conjugated pneumococcal capsular polysaccharides in persons who are genetically incapable of responding to unconjugated polysaccharides.
Musher DM; Groover JE; Watson DA; Rodriguez-Barradas MC; Baughn RE
Clin Infect Dis; 1998 Dec; 27(6):1487-90. PubMed ID: 9868665
[TBL] [Abstract][Full Text] [Related]
11. Conjugated polysaccharide vaccines.
Ahmad H; Chapnick EK
Infect Dis Clin North Am; 1999 Mar; 13(1):113-33, vii. PubMed ID: 10198795
[TBL] [Abstract][Full Text] [Related]
12. High antibody responses to booster doses of either Haemophilus influenzae capsular polysaccharide or conjugate vaccine after primary immunization with conjugate vaccines.
Käyhty H; Eskola J; Peltola H; Saarinen L; Mäkelä PH
J Infect Dis; 1992 Jun; 165 Suppl 1():S165-6. PubMed ID: 1588156
[No Abstract] [Full Text] [Related]
13. Immunoglobulin deficiency and idiotype expression in children developing Haemophilus influenzae type b disease after vaccination with conjugate vaccine. The Collaborative Study Group.
Holmes SJ; Lucas AH; Osterholm MT; Froeschle JE; Granoff DM
JAMA; 1991 Oct; 266(14):1960-5. PubMed ID: 1895474
[TBL] [Abstract][Full Text] [Related]
14. Antibacterial polysaccharide antibody deficiency after allogeneic bone marrow transplantation.
Quinti I; Velardi A; Le Moli S; Guerra E; D'Amelio R; Mastrantonio P; Martelli MF; Aiuti F
J Clin Immunol; 1990 May; 10(3):160-6. PubMed ID: 2114420
[TBL] [Abstract][Full Text] [Related]
15. Isotype concentrations of human antibodies to Haemophilus influenzae type b polysaccharide (Hib) in young adults immunized with the polysaccharide as such or conjugated to a protein (diphtheria toxoid).
Mäkelä O; Mattila P; Rautonen N; Seppälä I; Eskola J; Käyhty H
J Immunol; 1987 Sep; 139(6):1999-2004. PubMed ID: 3497985
[TBL] [Abstract][Full Text] [Related]
16. Titers of antibody to pneumococci in allogeneic bone marrow transplant recipients before and after vaccination with pneumococcal vaccine.
Giebink GS; Warkentin PI; Ramsay NK; Kersey JH
J Infect Dis; 1986 Oct; 154(4):590-6. PubMed ID: 3528315
[TBL] [Abstract][Full Text] [Related]
17. [Immunological principles of polysaccharide-protein conjugate vaccination].
Meyer M; Gahr M
Monatsschr Kinderheilkd; 1993 Oct; 141(10):770-6; quiz 777, 812-3. PubMed ID: 7505396
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to pneumococcal vaccine in children receiving bone marrow transplantation.
Avanzini MA; Carra AM; Maccario R; Zecca M; Pignatti P; Marconi M; Comoli P; Bonetti F; De Stefano P; Locatelli F
J Clin Immunol; 1995 May; 15(3):137-44. PubMed ID: 7559916
[TBL] [Abstract][Full Text] [Related]
19. Response of recent human immunodeficiency virus seroconverters to the pneumococcal polysaccharide vaccine and Haemophilus influenzae type b conjugate vaccine.
Weiss PJ; Wallace MR; Oldfield EC; O'Brien J; Janoff EN
J Infect Dis; 1995 May; 171(5):1217-22. PubMed ID: 7751696
[TBL] [Abstract][Full Text] [Related]
20. Anti-polyribosylribitol phosphate antibody levels 5 years after a primary series of Haemophilus influenzae type B conjugate vaccine.
Walter EB; Simmons SS; Clements DA
J Infect Dis; 1994 Oct; 170(4):1050-1. PubMed ID: 7930710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
